Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
136.5%EBIT Margin
VS
Market
Sector
Industry
History
$ 1.65Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information
Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCOHERUS ONCOLOGY INC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CHRS - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 194.89M | 136.5% | $ 142.77M |
| 3/31/2025 | $ -112.75M | -57.09% | $ 197.5M |
| 12/31/2024 | $ 55.66M | 20.85% | $ 266.96M |
| 9/30/2024 | $ 31.98M | 10.51% | $ 304.34M |
| 6/30/2024 | $ 7.62M | 2.47% | $ 308.13M |
| 3/31/2024 | $ -17.72M | -5.87% | $ 301.87M |
| 12/31/2023 | $ -197.73M | -76.86% | $ 257.24M |
| 9/30/2023 | $ -178.18M | -84.42% | $ 211.07M |
| 6/30/2023 | $ -227.54M | -125.07% | $ 181.93M |
| 3/31/2023 | $ -238.18M | -129.9% | $ 183.36M |
Key Performance Insights, Last 5 Years
- COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) EBIT % stands at 38.06%.
- Over the past 5 years, COHERUS ONCOLOGY INC's average EBIT % has been -39.24%.
- The median EBIT % for COHERUS ONCOLOGY INC during this period was -57.12%
- COHERUS ONCOLOGY INC reached its highest EBIT % over the past 5 years at 136.5%.
- The lowest EBIT % recorded by COHERUS ONCOLOGY INC in the same timeframe -129.9%
COHERUS ONCOLOGY INC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for COHERUS ONCOLOGY INC is calculated as follows: EBIT [ $ 186.19M ] / Revenues [ $ 489.26M ]
(=) EBIT % [ 38.06% ] CHRS - EBIT Margin, Last 5 years
-129.9%
Minimum
Mar 31, 2023
136.5%
Maximum
Jun 30, 2025
-39.24%
Average
-57.12%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.54% |
| median | 9.01% |
| std | 23.96% |